The analysis of PD-peripheral blood dataset integrating four GSE datasets showed that in peripheral blood, only the expression level of MAPKAPK2 was significantly higher in PD patients than in HCs (Fig. 4d, Supplementary Figs. 10 and 11). This evidence concerns the gene MAPKAPK2 and Parkinson disease.